about
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine recep...
Read More
3.85
0.14
(3.77%)
434.5K
XNAS Volume
XNAS 09 Jun, 2026 4:05 PM (EDT)
Board Meeting
The board meeting for X4 Pharma Inc is scheduled for today, for the purpose of X4 Pharmaceuticals Inc Annual General Meeting for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
X4 Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..